Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Total Liabilities (2018 - 2026)

TELA Bio has reported Total Liabilities over the past 8 years, most recently at $75.1 million for Q4 2025.

  • For Q4 2025, Total Liabilities rose 29.24% year-over-year to $75.1 million; the TTM value through Dec 2025 reached $75.1 million, up 29.24%, while the annual FY2025 figure was $75.1 million, 29.24% up from the prior year.
  • Total Liabilities for Q4 2025 was $75.1 million at TELA Bio, up from $60.0 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $75.1 million in Q4 2025 and troughed at $36.6 million in Q1 2021.
  • A 5-year average of $53.9 million and a median of $56.5 million in 2022 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: surged 36.96% in 2022 and later fell 1.78% in 2024.
  • Year by year, Total Liabilities stood at $42.4 million in 2021, then grew by 26.16% to $53.6 million in 2022, then increased by 10.49% to $59.2 million in 2023, then decreased by 1.78% to $58.1 million in 2024, then increased by 29.24% to $75.1 million in 2025.
  • Business Quant data shows Total Liabilities for TELA at $75.1 million in Q4 2025, $60.0 million in Q3 2025, and $58.4 million in Q2 2025.